| scholarly article | Q13442814 |
| P50 | author | Stephen B. McMahon | Q29653464 |
| Elizabeth J. Bradbury | Q56073852 | ||
| Anna K Clark | Q56860619 | ||
| Christoforos Tsantoulas | Q56860621 | ||
| P2093 | author name string | John Grist | |
| Fabien Marchand | |||
| Dalbinder Singh | |||
| P2860 | cites work | Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia | Q28199417 |
| P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury | Q28201682 | ||
| Etanercept reduces hyperalgesia in experimental painful neuropathy | Q28205689 | ||
| Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 | Q28505948 | ||
| A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia | Q29620385 | ||
| Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. | Q33198766 | ||
| Glial activation: a driving force for pathological pain | Q33953790 | ||
| Spinal cord glia: new players in pain | Q34341903 | ||
| Role of the immune system in chronic pain. | Q34431134 | ||
| Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. | Q34515061 | ||
| Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. | Q34568313 | ||
| Spinal cord injury pain--mechanisms and treatment | Q35641375 | ||
| Cell signaling and the genesis of neuropathic pain | Q35904210 | ||
| Neuroprotection and acute spinal cord injury: a reappraisal | Q36045235 | ||
| From discovery to clinical trials: treatment strategies for central neuropathic pain after spinal cord injury | Q36107416 | ||
| Spinal cord injury: a model of central neuropathic pain | Q36281896 | ||
| Etanercept: a review of its use in the management of rheumatoid arthritis | Q36830130 | ||
| The neuropathic pain triad: neurons, immune cells and glia | Q36983677 | ||
| CCL2 is a key mediator of microglia activation in neuropathic pain states | Q38500555 | ||
| Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. | Q39547001 | ||
| The Brown-Séquard syndrome. True or false? | Q39793308 | ||
| Differential expression of cytokines in painful and painless neuropathies | Q40198239 | ||
| Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions | Q42466912 | ||
| C-fos expression in the spinal cord of rats exhibiting allodynia following contusive spinal cord injury | Q42482614 | ||
| Mechanical and thermal allodynia in chronic central pain following spinal cord injury | Q42661597 | ||
| Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice | Q43977943 | ||
| Suppression of activated microglia promotes survival and function of transplanted oligodendroglial progenitors | Q44267937 | ||
| Inhibition of Microglial Activation Attenuates the Development but Not Existing Hypersensitivity in a Rat Model of Neuropathy | Q44432171 | ||
| Spinal blockade of TNF blocks spinal nerve ligation-induced increases in spinal P-p38. | Q44751504 | ||
| P2X7 receptor inhibition improves recovery after spinal cord injury | Q44982503 | ||
| TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord | Q46150604 | ||
| Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation | Q46442849 | ||
| Immunomodulatory effects of etanercept in an experimental model of spinal cord injury | Q46816845 | ||
| Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain | Q47891712 | ||
| Spinal AMPA receptor inhibition attenuates mechanical allodynia and neuronal hyperexcitability following spinal cord injury in rats. | Q48146236 | ||
| Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. | Q48328477 | ||
| Activation of spinal GABA receptors attenuates chronic central neuropathic pain after spinal cord injury. | Q48463096 | ||
| Painful mononeuropathy in C57BL/Wld mice with delayed wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity | Q48481248 | ||
| Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. | Q50707768 | ||
| Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. | Q50787458 | ||
| Expression of CCR2 in Both Resident and Bone Marrow-Derived Microglia Plays a Critical Role in Neuropathic Pain | Q56886107 | ||
| P433 | issue | 7 | |
| P921 | main subject | minocycline | Q415336 |
| P304 | page(s) | 673-681 | |
| P577 | publication date | 2008-10-11 | |
| P1433 | published in | European Journal of Pain | Q4548992 |
| P1476 | title | Effects of Etanercept and Minocycline in a rat model of spinal cord injury | |
| P478 | volume | 13 |
| Q35822433 | A consistent, quantifiable, and graded rat lumbosacral spinal cord injury model |
| Q38759777 | A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I. |
| Q35127468 | A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury |
| Q37774406 | AMPA-receptor trafficking and injury-induced cell death. |
| Q41949505 | Acute minocycline treatment mitigates the symptoms of mild blast-induced traumatic brain injury |
| Q89357167 | Anti-inflammatory effects of Metformin improve the neuropathic pain and locomotor activity in spinal cord injured rats: introduction of an alternative therapy |
| Q43966751 | Author's reply to Page: "Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept". |
| Q42579561 | Biologic TNFα-inhibitors that cross the human blood-brain barrier |
| Q37101851 | Biotic acts of antibiotics |
| Q34621522 | Blockade of TNF-α rapidly inhibits pain responses in the central nervous system |
| Q34458394 | Brain-penetrating tumor necrosis factor decoy receptor in the mouse |
| Q36296215 | Central nociceptive sensitization vs. spinal cord training: opposing forms of plasticity that dictate function after complete spinal cord injury |
| Q38263540 | Cerebrospinal Fluid Cytokines and Neurotrophic Factors in Human Chronic Pain Populations: A Comprehensive Review |
| Q98177456 | Chronic Pain After Spinal Cord Injury: Is There a Role for Neuron-Immune Dysregulation? |
| Q41813214 | Close encounters of the third kind: evidence for contact with TNF-alpha |
| Q34997940 | Current therapeutic strategies for inflammation following traumatic spinal cord injury |
| Q34204658 | Decrease in neuroimmune activation by HSV-mediated gene transfer of TNFα soluble receptor alleviates pain in rats with diabetic neuropathy |
| Q50326132 | Etanercept Prevents Histopathological Damage after Spinal Cord Injury in Rats. |
| Q36428524 | Etanercept treatment enhances clinical and neuroelectrophysiological recovery in partial spinal cord injury |
| Q33879278 | Forced exercise attenuates neuropathic pain in chronic constriction injury of male rat: an investigation of oxidative stress and inflammation |
| Q34839934 | Gap junction proteins and their role in spinal cord injury |
| Q57503290 | High-Frequency Transcutaneous Electrical Nerve Stimulation Alleviates Spasticity After Spinal Contusion by Inhibiting Activated Microglia in Rats |
| Q33971765 | Implications of gliotransmission for the pharmacotherapy of CNS disorders |
| Q28574797 | Inhibition of EGFR/MAPK signaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury |
| Q34221568 | Intraperitoneal Injection of Thalidomide Attenuates Bone Cancer Pain and Decreases Spinal Tumor Necrosis Factor-α Expression in a Mouse Model |
| Q37775104 | Is BDNF sufficient for information transfer between microglia and dorsal horn neurons during the onset of central sensitization? |
| Q36783527 | Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection |
| Q38167771 | Neuropathic pain and cytokines: current perspectives |
| Q35429973 | Neuroprotection with a brain-penetrating biologic tumor necrosis factor inhibitor |
| Q42321524 | Nociceptors as chronic drivers of pain and hyperreflexia after spinal cord injury: an adaptive-maladaptive hyperfunctional state hypothesis |
| Q33717608 | North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled study |
| Q48418747 | P2X7 receptor in the trigeminal sensory nuclear complex contributes to tactile allodynia/hyperalgesia following trigeminal nerve injury |
| Q33814688 | Peripheral inflammation induces tumor necrosis factor dependent AMPA receptor trafficking and Akt phosphorylation in spinal cord in addition to pain behavior |
| Q38819013 | Perispinal Delivery of CNS Drugs. |
| Q33947639 | Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence |
| Q37762260 | Perispinal etanercept: a new therapeutic paradigm in neurology |
| Q47106198 | Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury |
| Q54302983 | Pulsed radiofrequency inhibited activation of spinal mitogen-activated protein kinases and ameliorated early neuropathic pain in rats. |
| Q46473889 | Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases |
| Q39250156 | Regional TNFα mapping in the brain reveals the striatum as a neuroinflammatory target after ventricular fibrillation cardiac arrest in rats. |
| Q93388600 | Regulation of Inflammatory Cytokines for Spinal Cord Injury Repair Through Local Delivery of Therapeutic Agents |
| Q35894722 | Repetitive Treatment with Diluted Bee Venom Attenuates the Induction of Below-Level Neuropathic Pain Behaviors in a Rat Spinal Cord Injury Model |
| Q28391879 | Role of TNF-alpha during central sensitization in preclinical studies |
| Q42674268 | Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept |
| Q33703457 | Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein |
| Q41859986 | Sensory neuron downregulation of the Kv9.1 potassium channel subunit mediates neuropathic pain following nerve injury. |
| Q37950711 | Spatial and temporal activation of spinal glial cells: role of gliopathy in central neuropathic pain following spinal cord injury in rats |
| Q33897359 | Spinal cord transection-induced allodynia in rats--behavioral, physiopathological and pharmacological characterization |
| Q39844499 | Systemic but not local administration of retinoic acid reduces early transcript levels of pro-inflammatory cytokines after experimental spinal cord injury |
| Q33870861 | Systemic minocycline differentially influences changes in spinal microglial markers following formalin-induced nociception |
| Q37732472 | TNF-alpha and neuropathic pain--a review |
| Q34496543 | TNF-α contributes to spinal cord synaptic plasticity and inflammatory pain: distinct role of TNF receptor subtypes 1 and 2. |
| Q37849424 | Tetracyclines and pain |
| Q24650739 | The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia |
| Q38751303 | The Polarization States of Microglia in TBI: A New Paradigm for Pharmacological Intervention. |
| Q34711532 | The animal model of spinal cord injury as an experimental pain model |
| Q36590671 | The dual cyclooxygenase/5-lipoxygenase inhibitor licofelone attenuates p-glycoprotein-mediated drug resistance in the injured spinal cord |
| Q38019775 | The role of the immune system in the generation of neuropathic pain |
| Q59128671 | Therapeutic Evaluation of Tumor Necrosis Factor-alpha Antagonist Etanercept against Traumatic Brain Injury in Rats: Ultrastructural, Pathological, and Biochemical Analyses |
| Q37065365 | Validity of acute and chronic tactile sensory testing after spinal cord injury in rats |
| Q47215543 | γδ T cells provide the early source of IFN-γ to aggravate lesions in spinal cord injury |
Search more.